Rang	Name	Position
1	Mr. Christopher A. Viehbacher	President, CEO & Director
2	Ms. Robin C. Kramer	Executive VP & CFO
3	Ms. Nicole Murphy	Executive VP and Head of Pharmaceutical Operations & Technology
4	Dr. Priya Singhal M.D., M.P.H.	Executive VP & Head of Development
5	Mr. Sean Godbout	VP, Chief Accounting Officer & Global Corporate Controller
6	Mr. Guy Hadari	Chief Information Officer
7	Mr. Tim Power M.B.A., Ph.D.	Head of Investor Relations
8	Mr. Michael John Parini J.D.	Chief Legal Officer
9	Ms. Natacha Gassenbach	Chief Communication Officer & Head of Corporate Affairs
10	Mr. Adam Keeney Ph.D.	Executive VP & Head of Corporate Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	FMR Inc	12,33%	4,45 Mrd. USD
2	BlackRock Inc	10,82%	3,90 Mrd. USD
3	PRIMECAP Management Company	10,26%	3,70 Mrd. USD
4	Vanguard Capital Management, LLC	6,53%	2,36 Mrd. USD
5	State Street Corp	4,97%	1,79 Mrd. USD
6	Vanguard Portfolio Management, LLC	4,47%	1,61 Mrd. USD
7	Geode Capital Management, LLC	3,01%	1,09 Mrd. USD
8	Wellington Management Company LLP	2,11%	0,76 Mrd. USD
9	NORGES BANK	1,75%	0,63 Mrd. USD
10	Morgan Stanley - Brokerage Accounts	1,63%	0,59 Mrd. USD
11	AQR Capital Management LLC	1,31%	0,47 Mrd. USD
12	JPMorgan Chase & Co	1,23%	0,45 Mrd. USD
13	Amvescap Plc.	1,22%	0,44 Mrd. USD
14	Amundi	1,03%	0,37 Mrd. USD
15	Legal & General Group PLC	1,01%	0,36 Mrd. USD
16	Northern Trust Corp	0,97%	0,35 Mrd. USD
17	Boston Partners Global Investors, Inc	0,86%	0,31 Mrd. USD
18	UBS Asset Mgmt Americas Inc	0,85%	0,31 Mrd. USD
19	The Goldman Sachs Group Inc	0,83%	0,30 Mrd. USD
20	Dimensional Fund Advisors, Inc.	0,78%	0,28 Mrd. USD